NSE: EMCURE
|
BSE: 544210
1869.50
-19.70
(-1.04%)
110.8K
NSE+BSE Volume
NSE 23 Jul, 2026 3:31 PM (IST)
CDSCO Approval
Emcure Pharma secures CDSCO approval for Poviztra, targeting a $151 mn fatty liver market
See details